Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy

ID#: NCT06653400

Age: 18 years - 66+

Gender: Female

Healthy Subjects: Accepts Healthy Volunteers

Study Phase: Phase 1

Recruitment Status: Recruiting

Start Date: February 27, 2025

End Date: September 01, 2026

Contact Information:
Kathleen E Ackert, DO
212-241-4500
Virginia H Flatow, MD
Summary: A randomized double-blind placebo controlled trial comparing the effect of a combined ketorolac and lidocaine paracervical block with a standard lidocaine paracervical block on procedure related pain with office hysteroscopies.
Eligibility:

Inclusion Criteria:

- Patients assigned female at birth,

- booked for office hysteroscopy at Mount Sinai Hospital faculty practice associates.

Exclusion Criteria:

- Allergy to ketorolac or non-steroidal anti-inflammatory medications

- Allergy to lidocaine

- Presence of thrombocytopenia

- Contraindications to lidocaine

- History of gastritis or gastric ulcer

- Acute renal failure or chronic renal disease

- Chronic liver disease

- History of bleeding diathesis

- Long term narcotic use
Find a Clinical Trial Find Cancer Clinical Trials